Clinical Trial Update: The Effects of Bindarit in Preventing Stent Restenosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Bindarit to prevent restenosis after coronary stent placement has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Restenosis

Drugs mentioned

• Bindarit (Bindarit)

Snippet

Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A | Conditions: Coronary Restenosis | Phase 2 | Status: COMPLETED